title: Does erythropoietin augment the Ca(2+)-mediated K+ flow into the red blood cells in normotensive and hypertensive subjects?
authors.forename: M
authors.initials: M
authors.lastname: Buemi
authors.forename: D
authors.initials: D
authors.lastname: Marino
authors.forename: M T
authors.initials: MT
authors.lastname: Marino
authors.forename: A
authors.initials: A
authors.lastname: Allegra
authors.forename: F
authors.initials: F
authors.lastname: Squadrito
authors.forename: M S
authors.initials: MS
authors.lastname: Giacobbe
authors.forename: N
authors.initials: N
authors.lastname: Frisina
mesh_terms: D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D004357:Drug Synergism; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D004921:Erythropoietin / Q000494:pharmacology*; D005399:Fishes; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications; D011188:Potassium / Q000097:blood*; D012016:Reference Values; D014511:Uremia / Q000097:blood* / Q000150:complications
chemical_list: D004921:Erythropoietin; D011188:Potassium; D002118:Calcium